Selective attention and drug related attention bias in methadone maintenance patients

Acta Medica Iranica

Volumn 49, Issue 12, 2011, Pages 814-817

  Nejati, Majid ^a   Nejati, Vahid ^b   Mohammadi, Mohammad Reza ^c  

^a KASHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Addiction stroop test; Attention bias; Methadone maintenance therapy; Selective attention; Stroop color word test

Indexed keywords

METHADONE;

ACCURACY; ADDICTION STROOP TEST; ADULT; ARTICLE; ASSOCIATION; ATTENTION DISTURBANCE; DRUG DEPENDENCE; DRUG EFFECT; DRUG INDICATION; DRUG RELATED ATTENTION BIAS; FEMALE; HUMAN; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; RESPONSE TIME; SELECTIVE ATTENTION; STROOP TEST; TREATMENT DURATION; TREATMENT OUTCOME;

ADULT; ATTENTION; BIAS (EPIDEMIOLOGY); HUMANS; MALE; METHADONE; OPIOID-RELATED DISORDERS;

EID: 84856416856     PISSN: 00446025     EISSN: 17359694     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Darke S, Sims J, McDonald S, Wickes W. Cognitive impairment among methadone maintenance patients. Addiction 2000;95(5):687-95.
2. Specka M, Finkbeiner T, Lodemann E, Leifert K, Kluwig J, Gastpar M. Cognitive-motor performance of methadonemaintained patients. Eur Addict Res 2000;6(1):8-19.
3. Rapeli P, Fabritius C, Alho H, Salaspuro M, Wahlbeck K, Kalska H. Methadone vs. buprenorphine/naloxone during early opioid substitution treatment: a naturalistic comparison of cognitive performance relative to healthy controls. BMC Clin Pharmacol 2007;7:5.
4. Verdejo A, Toribio I, Orozco C, Puente KL, Pérez-García M. Neuropsychological functioning in methadone maintenance patients versus abstinent heroin abusers. Drug Alcohol Depend 2005;78(3):283-8.
5. Davis PE, Liddiard H, McMillan TM. Neuropsychological eficits and opiate abuse. Drug Alcohol Depend 2002;67(1):105-8.
6. Mintzer MZ, Stitzer ML. Cognitive impairment in methadone maintenance patients. Drug Alcohol Depend 2002;67(1):41-51.
7. Mintzer MZ, Copersino ML, Stitzer ML. Opioid abuse and cognitive performance. Drug Alcohol Depend 2005;78(2):225-30.
8. Prosser JM, Eisenberg D, Davey EE, Steinfeld M, Cohen LJ, London ED, Galynker II. Character pathology and neuropsychological test performance in remitted opiate dependence. Subst Abuse Treat Prev Policy 2008;3:23.
9. Bruce G, Jones BT. Methods that measure attentional bias. In: Wiers RW, Stacy AW, editors. Handbook on Implicit Cognition and Addiction. Thousand Oaks, CA: SAGE Publishers; 2006. p. 135-49.
10. Freudenreich O, Deckersbach T, Goff DC. Insight into current symptoms of schizophrenia. Association with frontal cortical function and affect. Acta Psychiatr Scand 2004;110(1):14-20.
11. Marks KA, Fastenau PS, Lysaker PH, Bond GR. Self- Appraisal of Illness Questionnaire (SAIQ): relationship to researcher-rated insight and neuropsychological function in schizophrenia. Schizophr Res 2000;45(3):203-11.
12. Stroop JR. Studies of interference in serial verbal reactions. J Exp Psychol 1935;18:643-62.
13. Rogers RD, Robbins TW. Investigating the neurocognitive deficits associated with chronic drug misuse. Curr Opin Neurobiol 2001;11(2):250-7.
14. Rogers RD, Robbins TW. The neuropsychology of chronic drug abuse. In: Ron MA, Robbins TW, editors. Disorders of Brain and Mind. Cambridge, UK: Cambridge University Press; 2003.
15. Verdejo A, Toribio I, Orozco C, Puente KL, Pérez-García M. Neuropsychological functioning in methadone maintenance patients versus abstinent heroin abusers. Drug Alcohol Depend 2005;78(3):283-8.
16. Bechara A, Damasio H. Decision-making and addiction (part I): impaired activation of somatic states in substance dependent individuals when pondering decisions with negative future consequences. Neuropsychologia 2002;40(10):1675-89.
17. Bechara A, Dolan S, Denburg N, Hindes A, Anderson SW, Nathan PE. Decision-making deficits, linked to a dysfunctional ventromedial prefrontal cortex, revealed in alcohol and stimulant abusers. Neuropsychologia 2001;39(4):376-89.
18. Bechara A, Dolan S, Hindes A. Decision-making and addiction (part II): myopia for the future or hypersensitivity to reward? Neuropsychologia 2002;40(10):1690-705.
19. Grant S, Contoreggi C, London ED. Drug abusers show impaired performance in a laboratory test of decision making. Neuropsychologia 2000;38(8):1180-7.
20. Fillmore MT. Drug abuse as a problem of impaired control: current approaches and findings. Behav Cogn Neurosci Rev 2003;2(3):179-97.
21. Hester R, Garavan H. Executive dysfunction in cocaine addiction: evidence for discordant frontal, cingulate, and cerebellar activity. J Neurosci 2004;24(49):11017-22.
22. Kaufman JN, Ross TJ, Stein EA, Garavan H. Cingulate hypoactivity in cocaine users during a GO-NOGO task as revealed by event-related functional magnetic resonance imaging. J Neurosci 2003;23(21):7839-43.
23. Ornstein TJ, Iddon JL, Baldacchino AM, Sahakian BJ, London M, Everitt BJ, Robbins TW. Profiles of cognitive dysfunction in chronic amphetamine and heroin abusers. Neuropsychopharmacology 2000;23(2):113-26.
24. Kreek MJ. Rationale for maintenance pharmacotherapy of opiate dependence. Res Publ Assoc Res Nerv Ment Dis 1992;70:205-30.
25. Tiffany ST. Cognitive concepts of craving. Alcohol Res Health 1999;23(3):215-24.
26. Walter M, Wiesbeck GA, Bloch N, Aeschbach S, Olbrich HM, Seifritz E, Dürsteler-MacFarland KM. Psychobiological responses to drug cues before and after methadone intake in heroin-dependent patients: a pilot study. Eur Neuropsychopharmacol 2008;18(5):390-3.
27. Kreek MJ, LaForge KS, Butelman E. Pharmacotherapy of addictions. Nat Rev Drug Discov 2002;1(9):710-26.
28. Kling MA, Carson RE, Borg L, Zametkin A, Matochik JA, Schluger J, Herscovitch P, Rice KC, Ho A, Eckelman WC, Kreek MJ. Opioid receptor imaging with positron emission tomography and [(18)F]cyclofoxy in long-term, methadone-treated former heroin addicts. J Pharmacol Exp Ther 2000;295(3):1070-6.
29. Schluger JH, Bart G, Green M, Ho A, Kreek MJ. Corticotropin-releasing factor testing reveals a dosedependent difference in methadone maintained vs control subjects. Neuropsychopharmacology 2003;28(5):985-94.
30. Schluger JH, Borg L, Ho A, Kreek MJ. Altered HPA axis responsivity to metyrapone testing in methadone maintained former heroin addicts with ongoing cocaine addiction. Neuropsychopharmacology 2001;24(5):568-75.